Within-host evolution of tandemly duplicated blaKPC14 conferring cross-resistance to ceftazidime-avibactam, cefiderocol and aztreonam-avibactam in hypervirulent ST11 Klebsiella pneumoniae
Open Access
- 11 July 2026
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 93 (2) , 106810
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2024MH197)
This publication has 29 references indexed in Scilit:
- Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: Driven by KPC-2 and OmpK36 mutationsInternational Journal of Antimicrobial Agents, 2024
- Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistanceInternational Journal of Antimicrobial Agents, 2024
- Emergence of ceftazidime-avibactam resistance through in-vivo blaKPC-2 to blaKPC-33 conversion during treatment of ST11 Klebsiella pneumoniae associated infectionsInternational Journal of Antimicrobial Agents, 2024
- Dynamic within-host cefiderocol heteroresistance caused by blaSHV-12 amplification in pandrug-resistant and hypervirulent Klebsiella pneumoniae sequence type 11Drug Resistance Updates, 2023
- Aztreonam-avibactam may not replace ceftazidime/avibactam: the case of KPC-21 carbapenemase and penicillin-binding protein 3 with four extra amino acidsInternational Journal of Antimicrobial Agents, 2022
- Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variantsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2022
- Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patientInternational Journal of Infectious Diseases, 2021
- Using SPAdes De Novo AssemblerCurrent Protocols in Bioinformatics, 2020
- Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimizationCurrent Opinion in Pharmacology, 2015
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973